D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 136 SEK 1.12% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Intangible Assets
kr49.3m
CAGR 3-Years
51%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Intangible Assets
kr46.2m
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Intangible Assets
kr14.2m
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Intangible Assets
kr4.3B
CAGR 3-Years
152%
CAGR 5-Years
63%
CAGR 10-Years
74%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Intangible Assets
kr48.1B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
34%
BioArctic AB
STO:BIOA B
Intangible Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2.2B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
123.02 SEK
Overvaluation 10%
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Intangible Assets?
Intangible Assets
49.3m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Intangible Assets amounts to 49.3m SEK.

What is Devyser Diagnostics AB's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
27%

Over the last year, the Intangible Assets growth was 50%. The average annual Intangible Assets growth rates for Devyser Diagnostics AB have been 51% over the past three years , 27% over the past five years .

Back to Top